Versant Venture Capital Vi, L.p.

Affiliations

  • at Lenz Therapeutics Inc. (LENZ), 2025-06-20
  • at Lava Therapeutics Nv (LVTX), 2025-02-07
  • at Monte Rosa Therapeutics Inc. (GLUE), 2024-10-30
  • at Black Diamond Therapeutics Inc. (BDTX), 2024-08-30
  • at Tempest Therapeutics Inc. (TPST), 2024-08-13
  • Large Shareholder at Contineum Therapeutics Inc. (CTNM), 2024-04-11
  • Large Shareholder at Oyster Point Pharma Inc. (OYST), 2023-01-04
  • Large Shareholder at Century Therapeutics Inc. (IPSC), 2022-08-11
  • Large Shareholder at Repare Therapeutics Inc. (RPTX), 2022-06-07
  • Large Shareholder at Aligos Therapeutics Inc. (ALGS), 2020-10-20
  • Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-21
  • Large Shareholder at Akero Therapeutics Inc. (AKRO), 2020-07-11
  • Large Shareholder at Passage Bio Inc. (PASG), 2020-03-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
GLUE $19.00 157,895 $3,000,005.00 2,097,938 2021-06-28 Filing
IPSC $20.00 100,000 $2,000,000.00 714,095 2021-06-22 Filing
ALGS $15.00 200,000 $3,000,000.00 862,444 2020-10-20 Filing
PASG $18.00 225,000 $4,050,000.00 933,352 2020-03-03 Filing
BDTX $19.00 396,081 $7,525,539.00 1,206,603 2020-02-03 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LENZ $30.25 133,924 $4,051,201.00 1,967,275 2025-06-20 Filing
LENZ $30.35 100,877 $3,061,616.95 1,047,912 2025-06-20 Filing
LENZ $29.95 100,000 $2,995,000.00 1,148,789 2025-06-18 Filing
LENZ $29.00 350,000 $10,150,000.00 1,248,789 2025-06-10 Filing
GLUE $9.41 15,600 $146,792.88 1,573,453 2024-10-29 Filing